LILRB4/CD85k/ILT3, Human, 重组蛋白 (hFc) TMPK-00603

Product Introduction
Bioactivity


英文名: LILRB4/CD85k/ILT3 Protein, Human, Recombinant (hFc)

描述: LILRB4,also known as CD85k and LIR-5, ILT3,  is an approximately 60 kDa transmembrane glycoprotein that negatively regulates immune cell activation. Mature human ILT3 consists of a 238 amino acid (aa) extracellular domain with two Ig-like domains, a 21 aa transmembrane segment, and a 168 aa cytoplasmic domain with 3 immunoreceptor tyrosine-based inhibitory motifs (ITIM).LILRB4 is receptor for class I MHC antigens. Recognizes a broad spectrum of HLA-A, HLA-B, HLA-C and HLA-G alleles.

存储条件: Lyophilized powder: -20~-80°C for 1 year | Solution: -80°C for 6~12 month

关键字: HM-18 | LILRB 4 | ILT 3 | LIR 5 | LIR-5 | HM 18 | LILRB-4

LILRB4/CD85k/ILT3, Human, 重组蛋白 (hFc) TMPK-00603信息由TargetMol中国为您提供，如您想了解更多关于LILRB4/CD85k/ILT3, Human, 重组蛋白 (hFc) TMPK-00603报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途